Thrombospondin is a 420-kD platelet alpha-granule glycoprotein that binds specifically to heparin. We examined adhesion to thrombospondin of CHO K1 cells and three mutant CHO lines with varying deficiencies in glycosaminoglycan (GAG) synthesis. In an experiment in which the parent line (K1) had 78% adherence to thrombospondin adsorbed to tissue culture plastic, CHO S745 cells, with less than 6% normal GAG synthesis had 11% adherence. CHO S677 cells, with decreased heparan sulfate proteoglycan but increased chondroitin sulfate proteoglycan, had 42% adherence. CHO S803 cells, with decreased heparan sulfate proteoglycan and normal chondroitin sulfate proteoglycan, had 31% adherence. Heparin inhibited K1 cell adhesion to thrombospondin, but not fibronectin, in a concentration-dependent manner. Dermatan sulfate but not chondroitin sulfate was also inhibitory. There was markedly decreased K1 cell adhesion to a thrombospondin core fragment that lacked the heparin binding NH2-terminal domain. Purified heparin binding domain, although poorly adhesive when adsorbed to substratum, inhibited cell adhesion to intact thrombospondin. Adhesion was better for all cell lines tested, including three human tumor cell lines, when thrombospondin was adsorbed at pH 4.0 compared with pH 7.4. When adsorption of thrombospondin was done at pH 7.4, cell adhesion was better when thrombospondin was adsorbed in the presence of greater than or equal to 0.6 mM calcium, compared to 0.1 mM calcium or EDTA. 
Introduction Thrombospondin (TSP)1 is a 420-kD glycoprotein found in platelet alpha granules (1, 2) . Endogenously synthesized 1 . Abbreviations used in this paper: ABS, acetate-buffered saline; CHO, Chinese hamster ovary; GAG, glycosaminoglycan; REDV, Arg-GluAsp-Val; RGD, Arg-Gly-Asp; TBS, Tris-buffered saline; TSP, thrombospondin.
thrombospondin is found in the extracellular matrix of several types of cells such as endothelial cells (3) (4) (5) (6) , aortic smooth muscle cells (6) , and fibroblasts (7) . A major function of platelet thrombospQndin appears to be stabilization of the fibrinogen bridges between platelets formed during platelet aggregation (8) (9) (10) . However, specific binding of heparin to the amino-terminal domain of thrombospondin and of type V collagen, laminin, fibronectin, fibrinogen, and plasminogen by the central portion of the molecule suggest other important functions (1, 2) .
Several investigators have looked at cell adhesion to adsorbed thrombospondin, or at cell binding and metabolism of soluble thrombospondin. Roberts et al. ( 11) showed that G36 1 melanoma cells adhere and spread while C32 cells adhere but do not spread on thrombospondin adsorbed to bacteriological plastic. The heparin binding domain appeared to be involved in the spreading of G36 1 cells, but not to play a major role in adhesion. Varani et al. (12) reported that a squamous cell carcinoma line adheres to thrombospondin adsorbed to tissue culture plastic and that several squamous cell carcinoma lines are stimulated to attach to type I or type IV collagen by thrombospondin. Tuszynski et al. (13) have shown that B16 melanoma and fibroblasts adhere to thrombospondin dried onto glass. McKeown-Longo et al. (14) reported that fibroblasts bind and metabolize thrombospondin, and Silverstein and Nachman (15) reported that thrombospondin binds to monocytes and macrophages, and mediates platelet-monocyte adhesion, probably via a glycoprotein receptor (16) . Several thrombospondin surface binding molecules have been identified. Thrombospondin binds to sulfated glycolipids on the membranes of human and sheep red blood cells (17) . Asch et al. identified an 88-kD surface glycoprotein recognized by the OKM5 antibody, and similar in properties to platelet glycoprotein IV, as the thrombospondin cell adhesion receptor on C32 melanoma cells (18) . This molecule appears to be the receptor for thrombospondin-mediated platelet-monocyte adhesion (16) . Heparin inhibits the binding of thrombospondin and its incorporation into the extracellular matrix by human fibroblasts (14) . Heparin, platelet factor 4, fucoidan, and betathromboglobulin inhibit binding of thrombospondin by endothelial cells, whereas fibronectin, vitronectin, and fibrinogen do not (19) .
Cell surface proteoglycans have properties that indicate that they may act as receptors for extracellular matrix proteins, including thrombospondin. These proteoglycans are tightly associated with the extracellular face of the plasma membrane (20) . Heparan sulfate proteoglycan may be bound to cell surface proteins, and be displaceable with heparin (21) , or may exist as integral membrane-bound proteoglycan (22) . Binding of heparan sulfate proteoglycan (23) (24) (25) (26) and dermatan sulfate proteoglycan (26) to fibronectin have been reported. Heparan sulfate proteoglycan also binds to laminin (27) , and to collagen types I, III, and V (25, (28) (29) (30) thrombospondin such that a particular thrombospondin domain either to be exposed or hidden, as has been suggested for fibronectin (35) , and that the change in conformation of thrombospondin caused by pH or calcium would effect cell adhesion.
Methods
Cell lines. The CHO parent line (Ki) and mutant lines (S745, S803, and S677) selected for deficiencies in glycosaminoglycan (GAG) synthesis have been described previously (31) (32) (33) . S745 is deficient in xylosyltransferase, which catalyzes the first sugar transfer step in glycosaminoglycan biosynthesis. The total sulfated GAG present on the cell surface of this line is < 6% of the amount present on the wild type cell line. The S803 cell line has cell surface sulfated GAG that is 16% of that in the wild type cells due to a defect in glycosaminoglycan elongation, with decreased heparan sulfate but normal chondroitin sulfate proteoglycans. The S677 cell line has 50% of cell surface sulfated GAG with decreased heparan sulfate but increased chondroitin sulfate compared with the wild type cell line. These cells were cultured in F12 medium supplemented with 10% FCS. Human cell lines were obtained from the American Type Culture Collection (Walkersville, MD). MG-63 is a human osteosarcoma line. G361 is a human melanoma line. C32 is a human amelanotic melanoma line. These were cultured in DME with 10% FCS.
Protein purification and labeling. Human TSP was purified from the releasate of human platelets by heparin affinity and gel filtration chromatography (9, 36) . Iodine-125 labeling was done by the chloramine-t method, followed by repurification by heparin affinity chromatography (14) . Unlabeled and labeled proteins were stored frozen in aliquots in Tris buffered saline (TBS, 150 mM sodium chloride, 10 mM Tris chloride, pH 7.4), containing 0.1 mM calcium chloride. Fragments of thrombospondin were prepared as follows. Trypsin at 1 Mg/ml to was added to TSP at 200 Ag/ml with trace '251I-labeled TSP in TBS containing 0.1 mM CaCl2. After 2 min at 22°C, then adding soybean trypsin inhibitor was added at 10 ug/ml. The fragments of thrombospondin were separated into core plus carboxy-terminal fragments and heparin binding fragments plus uncleaved thrombospondin by heparin affinity chromatography (37). Yield was determined by measuring 125I radioactivity and absorption at 280 nm. The unbound fraction was analyzed by SDS-PAGE after reduction and found to consist predominantly of a fragment of 68 kD and smaller fragments. The 68-kD band is the core fragment, but the fractionation should leave the carboxy-terminal fragment in the mixture. Purified heparin binding domain was prepared by incubating TSP at 300 ,ug/ml with trypsin at 25 Atg/ml for 30 min. This results in nearly complete cleavage of the heparin binding domains. The heparin binding domain was purified by heparin affinity chromatography, followed by a 0.55 M NaCI wash, which elutes the heparin binding domain from the heparin. Concentration was estimated by absorption at 280 nra, since the heparin binding domain is very poorly iodinated by the chloramine t method. Human fibronectin was purified from a side fraction of commercial coagulation Factor VIII production by the bromide method, as published (38) .
pH and calcium dependency of thrombospondin adsorption to plates. Costar 3596 96-well tissue culture plates (Costar Data Packaging Corp., Cambridge, MA) were used. TSP was diluted to 20 Ag/ml in acetate-buffered saline (ABS, 150 mM sodium chloride, 10 mM sodium acetate) adjusted to pH 4.0 or TBS adjusted to pH 7.4, each containing 10 mM EDTA, 0.1 mM calcium chloride, or 0.6 mM calcium chloride. It was found to be necessary to dilute thrombospondin into ABS rather than dialyze it against this buffer because ofprecipitation in the dialysis bag, presumably due to the insolubility of thrombospondin as it passes through its isoelectric point at pH 4.8.
Trace '251-labeled TSP was added to unlabeled TSP, and 100 Ml of saline at the different pHs, containing 500,000 cpm and 2 Mg of TSP was added per well. After 1 h of incubation at room temperature, the unbound TSP was washed offwith three washings ofTBS, pH 7.4 . The third washing from each well contained < 2% ofthe total counts in the unadsorbed fraction. 150 Ml of 1 N sodium hydroxide was added to each well to dissolve the adsorbed protein. After a 2-h incubation, the sodium hydroxide solution was collected, and the wells were washed twice with TBS, pH 7.4, which was collected. The second wash contained < 3% of the total counts of the adsorbed fraction. The washings were counted in a Micromedix ME gamma counter (Micromedic Systems, Horsham, PA). Four replicates of each pH and calcium concentration were used and the mean of the results is reported.
Adhesion assay. Cells for this assay were grown to confluence in F12 (for CHO lines) or DME (for all other cell lines) plus 10% FCS in 100 mm plastic petri dishes. Cells were detached with 3 ml 0.025% trypsin, 0.025% EDTA (Gibco Laboratories, Grand Island, NY). Cells that were detached with EDTA alone were released as clumps, causing unacceptable variability of results. In control experiments, MG-63 cells that were incubated for > 30 min at room temperature to recover from the detachment treatment showed no difference in adhesion whether detached with trypsin-EDTA or EDTA alone (data not shown). After 3 min incubation ofcells with trypsin-EDTA, the trypsin was inhibited with 0.5 ml of FCS, and a single cell suspension was prepared by repeated aspiration with a pasteur pipette. The cells were washed twice in 5. ml DME and resuspended in 5 ml DME. They were counted by hemocytometer with viability determined by trypan blue exclusion. Only cell suspensions with > 90% viability were used. Cells were either used unlabeled or they were labeled for 1 h with 0.1 mCi of 5'Cr as sodium chromate, followed by three washings in DME. After labeling, the viability was again tested and was > 90%. In all experiments except those specifically designed to study recovery from trypsinization, cells had at least 60 min at 37°C to recover from trypsin treatment.
Adherence was tested on protein-coated 96-well tissue culture plates prepared in the following manner. Thrombospondin or fibronectin was diluted to 20 g/ml in ABS, pH 4.0, orTBS, pH 7.4, with 10 mM EDTA, 0.1 mM calcium chloride or 0.6 mM calcium chloride.
Inhibitor studies were done on plates coated with thrombospondin at pH 4.0, with 0.1 mM calcium chloride. The appropriate protein solution, 100 Ml, was applied to the wells of the tissue culture plate, four replicates per experimental group. The plate was rinsed after 1 h incubation at room temperature. One set ofwells was used as a control and was not incubated with thrombospondin or fibronectin. To block nonspecific protein binding sites, 100 Ml of 5% BSA (99% pure, globulin (Fig. 1 ). There were -1.5 utg of thrombospondin 1 ). The NH2-terminal fragment labels poorly with 125i, and was not tested for adsorption.
Effect of pH and calcium concentration at adsorption on cell adhesion to thrombospondin. The effect of pH of thrombospondin adsorption (in the presence of 0.1 mM calcium) on adhesion and spreading of five cell lines is shown in Table I . Adherence for all cell lines was better on thrombospondin adsorbed at pH 4.0 than at pH 7.4. With thrombospondin adsorbed at pH 4.0, all cell lines except the CHO S745 cells adhered and all adherent lines, except CHO Kl, spread. G36 1 melanoma showed the greatest adhesion at both the pH 4.0 and pH 7.4 substrata. MG-63 had lower adhesion, but more adhered cells spread. C32 melanoma cells had lower adhesion and spreading than did MG-63 or G361. C32 cells did not spread on pH 7.4 substratum, in agreement with the results of Roberts et al. (1 1), but they did spread on pH 4.0 substratum.
There was considerable variability among experiments when conditions such as different tissue culture plates (even from the same lot), different TSP preparations and different BSA preparations were used. Results within a given experiment were consistent, however. The results shown in Table I coated wells at 15, 75, and 100 min after the second trypsinization, and adhesion was tested at 105 min after this trypsinization. Therefore the incubation times of the cells on the protein coated wells were 90, 30, and 5 min, but all cells had 105 min to recover from trypsin. Fig. 6 shows that the second trypsinization significantly inhibited cells adhesion to thrombospondin. CHO cell adhesion to thrombospondin cleavage fragment. CHO Kl and S745 cells were tested for adhesion to thrombospondin at 20 ,ug/ml and to the thrombospondin cleavage fragments minus heparin binding domains at the same molar concentration, both prepared at pH 4.0 in ABS. Table II shows that whereas 84% of CHO K I cells adhered to intact thrombospondin, less than 5% adhered to the cleavage fragments. CHO Kl cells showed 13.7% adhesion to purified TSP heparin binding domain, a value not substantially different than for control adhesion to BSA. Purified heparin binding domain, however, inhibited CHO Kl adhesion to intact TSP by about 45%.
Monoclonal antibody A2.5, directed against the heparin binding domain of TSP (39) , inhibited CHO Kl cell adhesion by about 33% at 10 ,g/ml, while monoclonal antibody 3.4.2, directed against the core fragment of TSP, did not inhibit, and perhaps enhanced, adhesion (Table II) .
Discussion
Role ofproteoglycans and other molecules in thrombospondin adhesion. We have explored the role of cell surface proteoglycans in cell adhesion to thrombospondin and the relationship of adhesion to binding and degradation of thrombospondin. We found that mutant CHO cell lines with decreased cell surface proteoglycans showed decreased cell adhesion to thrombospondin compared to the wild type cells, correlating with amounts of cell surface heparan sulfate and chondroitin sulfate proteoglycan. Heparin inhibited CHO cell -adhesion to thrombospondin at concentrations that also inhibited binding and degradation ( 19 CHO cells did not spread on thrombospondin while the others (MG-63, G361, and C32) both adhered and spread. This suggests that a second molecule is present on some cells that mediates interaction with thrombospondin. Heparin inhibited MG-63 cell adhesion (our results) and G361 cell spreading (I 1) to thrombospondin, suggesting that thrombospondin-proteoglycan interactions are important even when other molecules are operative.
Asch et al. showed that the OKM5 antibody, which binds to an 88-kD glycoprotein on platelets (platelet glycoprotein IV) and also binds to monocytes and macrophages, inhibits adhesion of C32 cells to thrombospondin (18) . Using affinity chromatography with the OKM5 antibody, they isolated an 88-kD glycoprotein from the surface of C32 cells with properties consistent with platelet GP IV. They showed that this protein binds thrombospondin and suggested that it may act as a cell surface thrombospondin receptor. G361 cells do not bind the OKM5 antibody and adhesion of G361 cells to thrombospondin is not inhibited by OKM5 (1 1). Thus, at least three potential thrombospondin receptors (heparan sulfate proteoglycan, GP IV and another receptor present on G361 cells) exist. The third receptor could be a member of the integrin family of cell surface molecules (43, 44) , inasmuch as thrombospondin has the Arg-Gly-Asp consensus sequence of integrin ligands (45) . In 40 ,ug/ml to glass at pH 5.5 (13). Calcium induces a substantial conformational change in thrombospondin (2) . Our findings that high calcium concentrations at adsorption enhance adhesion at pH 7.4 but not at pH 4.0 may be due to the small increase in amount of thrombospondin adsorbed at higher calcium but given the small differences in adhesion with large differences in concentration of adsorbed thrombospondin as seen in Fig. 3 , it is more likely to be due to a conformational change that exposed the same adhesion domain as when thrombospondin is adsorbed at low pH. This would account for the lack of synergy between low pH and high calcium.
Our data show, and Tuszynski et al. have reported, that the cell adhesion receptor for thrombospondin is more susceptible to trypsin than is the fibronectin cell adhesion receptor (13). Rapraeger (49) . A second cell adhesion site on fibronectin with an Arg-Glu-Asp-Val (REDV) sequence, similar to the RGD sequence, has been identified that is preferentially used over the RGD site for melanoma cell adhesion (50) . It Potential importance of cell adhesion to thrombospondin. Thrombospondin is an essential autocrine growth factor for smooth muscle cells, and is synergistic with epidermal growth factor in stimulating mitogenesis (51, 52) . This effect of thrombospondin is blocked by heparin. Cellular adhesion to thrombospondin that is present in human tissues may be an early step in the stimulation of growth of certain cells. This effect could be important in the diverse events listed above. Heparin inhibition of cell adhesion to thrombospondin by inhibition of interactions between cell surface proteoglycans, as suggested by our data, may be the mechanism by which heparin exerts antiproliferative effects in vitro and in vivo. Whereas fibronectin appears to be a long-term resident of the extracellular matrix, thrombospondin is apparently always a transient occupant of the matrix (14, 34, 36, 53) . Because of the transient nature of matrix thrombospondin, interactions with thrombospondin are probably also of a transient nature. Cells may deposit thrombospondin and bind to it, then metabolize the matrix thrombospondin and lift offat appropriate times. It could be expected that cell adhesion to thrombospondin would be more closely tied to changes in cell activity than adhesion to more permanent matrix molecules, and studies into the role of thrombospondin at times of accelerated cell growth and relocation such as embryogenesis and would healing may prove very fruitful in elucidating basic mechanisms.
Thrombospondin has been shown to be a chemotactic and haptotactic agent, and different domains of the molecule are involved in each activity (54) . Chemotaxis is mediated by the heparin binding amino-terminus while haptotaxis is mediated by the carboxy terminus. Cell adhesion to thrombospondin may be necessary for the haptotactic response.
Thrombospondin may be involved in tumor cell metastasis. The intravenous injection of thrombospondin before T24 1 sarcoma cell injection in mice results in enhanced lung colony formation and decreased clearance of tumor from the lungs (55) . There are two potential ways in which thrombospondin may be involved in tumor cell attachment and metastasis. Platelets are important to the metastatic process, perhaps by stabilizing interactions between tumor cells and the endothelial cell basement membrane (56) . Thrombospondin may be the platelet molecule involved in that process. Thrombospondin is found in the endothelial extracellular matrix (3). Therefore, cellular adhesion to thrombospondin may be involved directly in the attachment ofcells to the endothelial cell basement membrane, even though this does not seem to be the case for platelets (57) . Whether the finding of enhanced metastasis induced by co-injection of thrombospondin has a physiologic significance has not been established.
